Related Experiment Video
Updated: Apr 6, 2026

07:01
Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
9.7K
γ-Aminobutyric acid (GABA) administration improves action selection processes: a randomised controlled trial
Laura Steenbergen1, Roberta Sellaro1, Ann-Kathrin Stock2
1Institute for Psychological Research, Leiden Institute for Brain and Cognition, Leiden University, Leiden, The Netherlands.
Scientific Reports
|August 1, 2015
Summary
Gamma-aminobutyric acid (GABA) supplementation enhances action control, improving the ability to switch between tasks efficiently. This study provides evidence for GABA
Area of Science:
- Neuroscience
- Cognitive Psychology
- Pharmacology
Background:
- Real-world tasks demand rapid action control and efficient response sequencing.
- The gamma-aminobutyric acid (GABA)-ergic system is implicated in modulating action cascading.
- Understanding GABA's role is crucial for cognitive enhancement strategies.
Purpose of the Study:
- To investigate the causal role of the GABA-ergic system in action cascading.
- To determine if synthetic GABA administration affects the efficiency of switching between responses.
Main Methods:
- A double-blind, randomized, between-group study with 30 healthy adults.
- Participants received either 800 mg of synthetic GABA or a placebo (microcrystalline cellulose).
- Performance was assessed using a stop-change paradigm measuring action selection under interruption.
Main Results:
- GABA administration significantly increased action selection compared to placebo.
- This improvement was observed when participants had to simultaneously stop and change a response.
- Enhanced action selection was also noted when the change occurred post-interruption.
Conclusions:
- Systemic administration of synthetic GABA causally modulates action cascading performance.
- The GABA-ergic system plays a key role in the efficiency of response sequencing and adaptation.
- Findings suggest potential applications for GABA in cognitive training and intervention.
Related Concept Videos
Antiepileptic Drugs: GABAergic Pathway Potentiators
1.7K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.7K
Antiepileptic Drugs: Potassium Channel Activators
973
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
973
Antiepileptic Drugs: Glutamate Antagonists
1.2K
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.2K

